Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × perifosine × Clear all

NCT00058214 2015-02-23

Perifosine in Treating Patients With Recurrent Prostate Cancer

Phase 2 Terminated

25 enrolled 5 charts

Prostatic Neoplasms

NCT00060437 2013-06-19

Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms